Anti-egfr antibody drug conjugates

The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.

Saved in:
Bibliographic Details
Main Authors PHILLIPS Andrew C, JUDD Andrew S, BRUNCKO Milan, BOGHAERT Erwin R, SOUERS Andrew J
Format Patent
LanguageEnglish
Hebrew
Published 31.01.2019
Online AccessGet full text

Cover

More Information
Summary:The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.
Bibliography:Application Number: IL20180263571